Square Pharmaceuticals PLC

Established in 1958, Square Pharmaceuticals PLC is the premier pharmaceutical company in Bangladesh, holding the undisputed top market position continuously since 1985. Evolving from a modest partnership into a massive multinational enterprise, Square currently employs over 12,500 people and serves as a cornerstone of the nation's healthcare infrastructure. The company operates two highly advanced, world-class manufacturing facilities in Pabna and Dhaka, equipped with cutting-edge technology to produce over 850 distinct products. While highly renowned for its human generic medicines and vaccines, Square launched its AgroVet division in 1998 to address the critical needs of the agricultural sector. Today, the division provides a comprehensive portfolio of locally manufactured and imported livestock and poultry solutions, significantly advancing the agro-business landscape in Bangladesh. A trailblazer in international trade, Square pioneered pharmaceutical exports from Bangladesh in 1987. Today, its products reach over 45 countries across Asia, Africa, Europe, and the Americas. This global trust is underpinned by an unwavering commitment to quality control and strict adherence to WHO GMP standards. Square’s facilities boast prestigious international certifications, including approvals from the USFDA, Australia's TGA, and South Africa's MCC, along with an ISO 9001 certification achieved in 1998. Driven by a forward-thinking vision, Square Pharmaceuticals remains dedicated to continuous investment, ethical operations, and the holistic well-being of the communities it serves.